US Stock MarketDetailed Quotes

REVB Revelation Biosciences

Watchlist
  • 0.3600
  • -0.0526-12.75%
Close Dec 13 16:00 ET
  • 0.3700
  • +0.0100+2.78%
Post 18:28 ET
1.55MMarket Cap-0.02P/E (TTM)

Revelation Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-439.24%-9.26M
-24.46%-2.48M
-80.17%-2.84M
35.06%-7.29M
-111.39%-2M
0.85%-1.72M
46.32%-1.99M
67.39%-1.58M
-1.16%-11.22M
67.09%-947.47K
Net income from continuing operations
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
98.89%-120.25K
-82.42%-2.2M
-124.51%-2.63M
21.07%-1.45M
193.09%6.16M
9.65%-10.83M
68.72%-1.21M
Operating gains losses
93.47%-6.04K
98.96%-4.42K
99.12%-68.43K
---8.33M
---68.2K
---92.56K
---423.24K
---7.74M
----
----
Depreciation and amortization
15.30%7.22K
15.30%7.22K
-0.02%6.26K
0.00%25.05K
0.00%6.26K
0.00%6.26K
0.00%6.26K
0.02%6.26K
49.26%25.05K
0.00%6.26K
Other non cash items
----
----
----
----
----
----
----
----
-71.44%14.96K
--0
Change In working capital
-829.76%-7.05M
3,247.47%5.85M
-355.37%-126.47K
234.36%982.14K
3.80%229.91K
258.96%965.9K
90.57%-185.9K
-101.71%-27.77K
-305.20%-730.97K
-74.08%221.5K
-Change in prepaid assets
-91.89%7.9K
-165.39%-53.87K
104.94%12.82K
-102.03%-11.56K
-71.27%67.95K
-63.37%97.38K
-24.63%82.38K
-508.52%-259.26K
211.72%569.04K
-74.50%236.5K
-Change in payables and accrued expense
-912.48%-7.06M
2,301.11%5.91M
-223.53%-210.41K
174.59%911.62K
205.61%141.05K
199.43%868.52K
87.11%-268.28K
-89.90%170.33K
-233.40%-1.22M
181.88%46.15K
-Change in other current liabilities
----
----
----
--0
----
----
----
----
66.89%-16.75K
--0
-Change in other working capital
--0
--0
16.32%71.13K
234.20%82.07K
--20.92K
--0
--0
--61.15K
---61.15K
----
Cash from discontinued investing activities
Operating cash flow
-439.24%-9.26M
-24.46%-2.48M
-80.17%-2.84M
35.06%-7.29M
-111.39%-2M
0.85%-1.72M
46.32%-1.99M
67.39%-1.58M
-1.16%-11.22M
67.09%-947.47K
Investing cash flow
Cash flow from continuing investing activities
-17.69K
0
-19.17K
0
0
0
Net PPE purchase and sale
---17.69K
--0
---19.17K
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
---17.69K
--0
---19.17K
----
----
--0
--0
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
3.74M
0
-61.37%5.42M
-7.72%14.03M
0
0
15
30.57%14.02M
89.86%15.2M
5K
Net issuance payments of debt
----
----
----
--0
----
----
----
----
---796.88K
--0
Net common stock issuance
--0
--0
-61.39%5.42M
215.21%14.03M
--0
--0
--0
93.19%14.03M
641.85%4.45M
--0
Net preferred stock issuance
--0
--0
--0
-200.00%-5K
--0
--0
--0
---5K
-99.93%5K
--5K
Proceeds from stock option exercised by employees
--3.74M
--0
568.42%127
-99.33%34
--0
--0
--15
-99.63%19
--5.09K
--0
Net other financing activities
----
----
----
----
----
----
----
----
--11.53M
--0
Cash from discontinued financing activities
Financing cash flow
--3.74M
--0
-61.37%5.42M
-7.72%14.03M
--0
--0
--15
30.57%14.02M
89.86%15.2M
--5K
Net cash flow
Beginning cash position
-23.16%12.07M
-17.80%14.55M
128.28%11.99M
312.09%5.25M
125.88%13.99M
352.02%15.71M
146.34%17.7M
312.09%5.25M
-71.62%1.27M
49.74%6.2M
Current changes in cash
-222.25%-5.53M
-24.46%-2.48M
-79.44%2.56M
69.39%6.74M
-112.51%-2M
-163.12%-1.72M
46.32%-1.99M
110.60%12.45M
223.64%3.98M
67.08%-942.47K
End cash Position
-53.26%6.54M
-23.16%12.07M
-17.80%14.55M
128.28%11.99M
128.28%11.99M
125.88%13.99M
352.02%15.71M
146.34%17.7M
312.09%5.25M
312.09%5.25M
Free cash flow
-440.27%-9.27M
-24.46%-2.48M
-81.39%-2.86M
35.06%-7.29M
-111.39%-2M
0.85%-1.72M
46.32%-1.99M
67.39%-1.58M
0.03%-11.22M
66.90%-947.47K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -439.24%-9.26M-24.46%-2.48M-80.17%-2.84M35.06%-7.29M-111.39%-2M0.85%-1.72M46.32%-1.99M67.39%-1.58M-1.16%-11.22M67.09%-947.47K
Net income from continuing operations 14.72%-2.24M-479.34%-8.39M-143.54%-2.68M98.89%-120.25K-82.42%-2.2M-124.51%-2.63M21.07%-1.45M193.09%6.16M9.65%-10.83M68.72%-1.21M
Operating gains losses 93.47%-6.04K98.96%-4.42K99.12%-68.43K---8.33M---68.2K---92.56K---423.24K---7.74M--------
Depreciation and amortization 15.30%7.22K15.30%7.22K-0.02%6.26K0.00%25.05K0.00%6.26K0.00%6.26K0.00%6.26K0.02%6.26K49.26%25.05K0.00%6.26K
Other non cash items ---------------------------------71.44%14.96K--0
Change In working capital -829.76%-7.05M3,247.47%5.85M-355.37%-126.47K234.36%982.14K3.80%229.91K258.96%965.9K90.57%-185.9K-101.71%-27.77K-305.20%-730.97K-74.08%221.5K
-Change in prepaid assets -91.89%7.9K-165.39%-53.87K104.94%12.82K-102.03%-11.56K-71.27%67.95K-63.37%97.38K-24.63%82.38K-508.52%-259.26K211.72%569.04K-74.50%236.5K
-Change in payables and accrued expense -912.48%-7.06M2,301.11%5.91M-223.53%-210.41K174.59%911.62K205.61%141.05K199.43%868.52K87.11%-268.28K-89.90%170.33K-233.40%-1.22M181.88%46.15K
-Change in other current liabilities --------------0----------------66.89%-16.75K--0
-Change in other working capital --0--016.32%71.13K234.20%82.07K--20.92K--0--0--61.15K---61.15K----
Cash from discontinued investing activities
Operating cash flow -439.24%-9.26M-24.46%-2.48M-80.17%-2.84M35.06%-7.29M-111.39%-2M0.85%-1.72M46.32%-1.99M67.39%-1.58M-1.16%-11.22M67.09%-947.47K
Investing cash flow
Cash flow from continuing investing activities -17.69K0-19.17K000
Net PPE purchase and sale ---17.69K--0---19.17K----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow ---17.69K--0---19.17K----------0--0--0--------
Financing cash flow
Cash flow from continuing financing activities 3.74M0-61.37%5.42M-7.72%14.03M001530.57%14.02M89.86%15.2M5K
Net issuance payments of debt --------------0-------------------796.88K--0
Net common stock issuance --0--0-61.39%5.42M215.21%14.03M--0--0--093.19%14.03M641.85%4.45M--0
Net preferred stock issuance --0--0--0-200.00%-5K--0--0--0---5K-99.93%5K--5K
Proceeds from stock option exercised by employees --3.74M--0568.42%127-99.33%34--0--0--15-99.63%19--5.09K--0
Net other financing activities ----------------------------------11.53M--0
Cash from discontinued financing activities
Financing cash flow --3.74M--0-61.37%5.42M-7.72%14.03M--0--0--1530.57%14.02M89.86%15.2M--5K
Net cash flow
Beginning cash position -23.16%12.07M-17.80%14.55M128.28%11.99M312.09%5.25M125.88%13.99M352.02%15.71M146.34%17.7M312.09%5.25M-71.62%1.27M49.74%6.2M
Current changes in cash -222.25%-5.53M-24.46%-2.48M-79.44%2.56M69.39%6.74M-112.51%-2M-163.12%-1.72M46.32%-1.99M110.60%12.45M223.64%3.98M67.08%-942.47K
End cash Position -53.26%6.54M-23.16%12.07M-17.80%14.55M128.28%11.99M128.28%11.99M125.88%13.99M352.02%15.71M146.34%17.7M312.09%5.25M312.09%5.25M
Free cash flow -440.27%-9.27M-24.46%-2.48M-81.39%-2.86M35.06%-7.29M-111.39%-2M0.85%-1.72M46.32%-1.99M67.39%-1.58M0.03%-11.22M66.90%-947.47K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data